Results 181 to 190 of about 6,419,415 (265)

Guidelines for the administration of blood and blood components

, 2004
National Blood Users Group
core  

Association of Anaesthetists guidelines: the use of blood components and their alternatives. [PDF]

Anaesthesia
Shah A, Klein AA, Agarwal S, Lindley A, Ahmed A, Dowling K, Jackson E, Das S, Raviraj D, Collis R, Sharrock A, Stanworth SJ, Moor P.   +12 more
europepmc   +1 more source

A Pilot Study on Blood Components in COVID-19 Affected Subjects: A Correlation to UPR Signalling and ER-Stress. [PDF]

Indian J Clin Biochem, 2023
Bansal A, Kumar S, Rai N, Kumari S, Kumar V, Kumar A, Chandra NC.   +6 more
europepmc   +1 more source

Unique circulating miRNAome signatures captured with distinct molecular states in Lynch syndrome and sporadic colorectal cancer

Molecular Oncology, EarlyView.
Circulating microRNA profiles distinguish nonmalignant Lynch syndrome from cancer‐associated Lynch syndrome, sporadic colorectal cancer, and healthy controls. Age‐stratified analysis reveals disease‐specific regulatory states, and a six‐miRNA panel shows concordant separation in an independent colorectal tissue cohort.
Ramadhani Salum Chambuso, Md Shohel Ul Islam, Rosa M Xicola, Raj Ramesar, Xavier Llor, Sinclair Steele   +5 more
wiley   +1 more source

An evaluation of blood components storage duration toward determining the reference intervals of coagulopathic metabolic analytes - A cross-sectional analytical study. [PDF]

Asian J Transfus Sci
Sharma S, Patel S, Patel M, Jain A, Yadav P.   +4 more
europepmc   +1 more source

Interaction of the Blood Components with Ascending Thoracic Aortic Aneurysm Wall: Biomechanical and Fluid Analyses. [PDF]

Life (Basel), 2022
Taheri RA, Razaghi R, Bahramifar A, Morshedi M, Mafi M, Karimi A.   +5 more
europepmc   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

Molecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David, Arthur Karaulic, Audrey Bennetot, Clémence Fournier, Quentin Odet, Arthur Gouraud, Isabelle Bourget, Cédric Gaggioli, Sandy Giuliano, Frédéric Luciano, Olivier Léger, Zaki Sellam, Gilles Pagès   +12 more
wiley   +1 more source

A Direct Comparison of the Performance of HemoCue Plasma/Low HB Analyzer versus Optical Spectroscopy for Quality Control Measurements of Free Hemoglobin in Blood Components. [PDF]

Transfus Med Hemother
Siller A, Seekircher L, Schmidt D, Tschiderer L, Willeit P, Schennach H, Amato M.   +6 more
europepmc   +1 more source

Effects of light intensity on growth performance, blood components, carcass characteristics, and welfare of broilers. [PDF]

J Anim Sci Technol, 2022
Kim HJ, Son J, Kim HS, Hong EC, Kim JH.
europepmc   +1 more source

Engineering IL‐4 resistant proinflammatory human myeloid cells for cancer immunotherapy

Molecular Oncology, EarlyView.
We developed a scalable workflow to generate proinflammatory human myeloid cells. CRISPR/Cas9‐edited CD34+ hematopoietic stem and progenitor cells were expanded and differentiated with M‐CSF. Deletion of STAT6 or STAT6/NFKB1 enhanced macrophage proinflammatory gene expression and cytokine secretion in the presence of IL‐4 while maintaining antibody ...
Theresa Barberi, Alan D. Friedman
wiley   +1 more source